Healthcare · Pharmaceuticals & Biotechnology
Emcure Pharmaceuticals Limited (Emcure) is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules (both softgel capsules and hard-gel capsules) and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals.
Source: Wikipedia
| Fiscal year | Mar 26 | Mar 25 |
|---|---|---|
| Total income (before exceptional items) | 5,453† | 4,511† |
| Net profit | 733 | 317 |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| Mukund Keshao Gurjar | Executive Director | June 30, 2026 |
| Namita Vikas Thapar | Executive Director | June 30, 2026 |
| Samit Satish Mehta | Executive Director | June 30, 2026 |
| Satish Ramanlal Mehta | Executive Director | June 30, 2026 |
| Sunil Rajanikant Mehta | Executive Director | June 30, 2026 |
| Chinnadharavaram Sundaresan Muralidharan | Independent Director | June 30, 2026 |
| Palamadai Sundararajan Jayakumar | Independent Director | June 30, 2026 |
| Shailesh Kripalu Ayyangar | Independent Director | June 30, 2026 |
| Vidya Rajiv Yeravdekar | Independent Director | June 30, 2026 |
| Vijay Keshav Gokhale | Independent Director | June 30, 2026 |
| Berjis Minoo Desai | Non-Executive Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
